FDA Approves New Broad-Spectrum Sunscreen Ingredient
FDA Approves New Broad-Spectrum Sunscreen Ingredient
US · Published Jun 12, 2026
The U.S.
Food and Drug Administration (FDA) has approved bemotrizinol (BEMT) as a new ingredient for sunscreen formulations, marking the first such approval in over 25 years.

Why It's Important?

The approval of BEMT is a significant advancement in sun protection, offering U.S. consumers access to more effective and longer-lasting sunscreens. This is particularly important for reducing the risks of skin cancer and sunburn caused by UVB rays, as well as premature aging linked to UVA exposure. The ingredient's safety has been confirmed through multiple studies, including tests showing minimal absorption into the bloodstream and no evidence of cancer or reproductive harm. However, users should continue to follow general sun safety practices, including reapplication after swimming or sweating.

Related News